Learn About Transient Familial Hyperbilirubinemia

What is the definition of Transient Familial Hyperbilirubinemia?

Transient familial hyperbilirubinemia is a metabolic disorder that is passed down through families. Babies with this disorder are born with severe jaundice.

What are the alternative names for Transient Familial Hyperbilirubinemia?

Lucey-Driscoll syndrome

What are the causes of Transient Familial Hyperbilirubinemia?

Transient familial hyperbilirubinemia is an inherited disorder. It occurs when the body does not properly break down (metabolize) a certain form of bilirubin. Bilirubin levels rapidly build up in the body. The high levels are poisonous to the brain and can cause death.

What are the symptoms of Transient Familial Hyperbilirubinemia?

The newborn may have:

  • Yellow skin (jaundice)
  • Yellow eyes (icterus)
  • Lethargy

If untreated, seizures and neurologic problems (kernicterus) may develop.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Transient Familial Hyperbilirubinemia?

Phototherapy with blue light is used to treat the high level of bilirubin. An exchange transfusion is sometimes necessary if the levels are extremely high.

Who are the top Transient Familial Hyperbilirubinemia Local Doctors?
Christopher T. Messitt
Distinguished in Transient Familial Hyperbilirubinemia
Distinguished in Transient Familial Hyperbilirubinemia

Atrium Health Concierge Care Lake Norman

9623 Bailey Road, Suite 220, 
Cornelius, NC 
Languages Spoken:
English
Accepting New Patients

Christopher Messitt is a primary care provider, practicing in Family Medicine in Cornelius, North Carolina. Dr. Messitt is rated as a Distinguished provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. His top areas of expertise are Transient Familial Hyperbilirubinemia, Thyroid Dysgenesis, Congenital Hypothyroidism, and Newborn Jaundice. Dr. Messitt is currently accepting new patients.

Elite in Transient Familial Hyperbilirubinemia
Elite in Transient Familial Hyperbilirubinemia
725 Welch Rd, 
Palo Alto, CA 
Languages Spoken:
English

Vinod Bhutani is a Neonatologist in Palo Alto, California. Dr. Bhutani is rated as an Elite provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. His top areas of expertise are Bilirubin Encephalopathy, Transient Familial Hyperbilirubinemia, Hemolytic Disease of the Newborn, and Jaundice.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Transient Familial Hyperbilirubinemia
Neonatology | Pediatrics
Elite in Transient Familial Hyperbilirubinemia
Neonatology | Pediatrics
750 Welch Rd, Suite 315, 
Palo Alto, CA 
Languages Spoken:
English

David Stevenson is a Neonatologist and a Pediatrics provider in Palo Alto, California. Dr. Stevenson is rated as an Elite provider by MediFind in the treatment of Transient Familial Hyperbilirubinemia. His top areas of expertise are Transient Familial Hyperbilirubinemia, Newborn Jaundice, Jaundice, and Bilirubin Encephalopathy.

What is the outlook (prognosis) for Transient Familial Hyperbilirubinemia?

Babies who are treated can have a good outcome. If the condition is not treated, severe complications develop. This disorder tends to improve with time.

What are the possible complications of Transient Familial Hyperbilirubinemia?

Death or severe brain and nervous system (neurological) problems can occur if the condition is not treated.

When should I contact a medical professional for Transient Familial Hyperbilirubinemia?

This problem is most often found immediately after delivery. However, contact your health care provider if you notice your baby's skin turning yellow. There are other causes for jaundice in the newborn that are easily treated.

Genetic counseling can help families understand the condition, its risks of recurring, and how to care for the person.

How do I prevent Transient Familial Hyperbilirubinemia?

Phototherapy can help prevent serious complications of this disorder.

What are the latest Transient Familial Hyperbilirubinemia Clinical Trials?
A Prospective Open-label Randomized Controlled Trial , Evaluating the Efficacy of Ursodeoxycholic Acid (UDCA) as an Adjuvant to Phototherapy in Neonates With Indirect Hyperbilirubinemia

Summary: This is a prospective, open-label, randomized controlled trial conducted at Lattakia University Hospital (Tishreen University), aiming to evaluate the efficacy of Ursodeoxycholic Acid (UDCA) as an adjuvant to triple phototherapy in the management of indirect hyperbilirubinemia in neonates ≥34 weeks of gestation. Eligible neonates will be randomly assigned to one of two groups: Group A: continuous ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
COMPARATIVE EFFECTS OF ZINC AND PROBIOTICS ON NEONATAL INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY

Summary: Study will evaluate effects of oral zinc and probiotics supplementation in neonates who have indirect hyperbilirubinemia and are receiving phototherapy. Aim is to compare efficacy of these two drugs in clearing bilirubin and reducing duration of phototherapy. Neonates will be randomly assigned to receive either drug alongside phototherapy.

Who are the sources who wrote this article ?

Published Date: September 18, 2023
Published By: Anna C. Edens Hurst, MD, MS, Associate Professor in Medical Genetics, The University of Alabama at Birmingham, Birmingham, AL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Korenblat KM. Approach to the patient with jaundice or abnormal liver tests. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 133.

National Center for Advancing Translational Sciences. Genetic and Rare Diseases Information Center website. Lucey-Driscoll syndrome. rarediseases.info.nih.gov/diseases/2791/transient-familial-neonatal-hyperbilirubinemia. Updated September 2025. Accessed October 15, 2025.

Rosenberg WMC, Badrick T, Lo SF, Tanwar S. Liver disease. In: Rifai N, Chiu RWK, Young I, Burnham CAD, Wittwer CT, eds. Tietz Textbook of Laboratory Medicine. 7th ed. St Louis, MO: Elsevier; 2023:chap 51.

Taylor TD, Wheatley MA, Lidofsky SD. Jaundice. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 11th ed. Philadelphia, PA: Elsevier; 2021:chap 21.